Lok, Sheau W ;
Whittle, James R ;
Vaillant, François...
Lok , S W , Whittle , J R , Vaillant , F , Teh , C E , Lo , L L , Policheni , A N , Bergin , A R T , Desai , J , Ftouni , S , Gandolfo , L C , Liew , D , Liu , H K , Mann , G B , Moodie , K , Murugasu , A , Pal , B , Roberts , A W , Rosenthal , M A , Shackleton , K , Silva , M J , Siow , Z R , Smyth , G K , Taylor , L , Travers , A , Yeo , B , Yeung , M M , Bujak , A Z , Dawson , S J , Gray , D H D , Visvader , J E & Lindeman , G J 2019 , ' A phase Ib dose-escalation and expansion study of the BCL2 inhibitor venetoclax combined with tamoxifen in ER and BCL2– positive metastatic breast cancer ' , Cancer Discovery , vol. 9 , no. 3 , pp. 354-369 . https://doi.org/10.1158/2159-8290.CD-18-1151.
,
2019
